330 related articles for article (PubMed ID: 14528051)
1. Tau protein in familial and sporadic diseases.
Yancopoulou D; Spillantini MG
Neuromolecular Med; 2003; 4(1-2):37-48. PubMed ID: 14528051
[TBL] [Abstract][Full Text] [Related]
2. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
3. Hereditary frontotemporal dementia caused by Tau gene mutations.
van Swieten J; Spillantini MG
Brain Pathol; 2007 Jan; 17(1):63-73. PubMed ID: 17493040
[TBL] [Abstract][Full Text] [Related]
4. Tau alternative splicing in familial and sporadic tauopathies.
Niblock M; Gallo JM
Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
[TBL] [Abstract][Full Text] [Related]
5. Tau gene mutations: dissecting the pathogenesis of FTDP-17.
Ingram EM; Spillantini MG
Trends Mol Med; 2002 Dec; 8(12):555-62. PubMed ID: 12470988
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of tau isoform transcripts in sporadic tauopathies.
Connell JW; Rodriguez-Martin T; Gibb GM; Kahn NM; Grierson AJ; Hanger DP; Revesz T; Lantos PL; Anderton BH; Gallo JM
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):104-9. PubMed ID: 15950767
[TBL] [Abstract][Full Text] [Related]
7. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Spillantini MG; Van Swieten JC; Goedert M
Neurogenetics; 2000 Mar; 2(4):193-205. PubMed ID: 10983715
[TBL] [Abstract][Full Text] [Related]
8. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
[TBL] [Abstract][Full Text] [Related]
9. [Tauopathies--a new class of neurodegenerative diseases].
Ludolph AC; Sperfeld A; Collatz BM; Storch A
Nervenarzt; 2001 Feb; 72(2):78-85. PubMed ID: 11256158
[TBL] [Abstract][Full Text] [Related]
10. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
Rademakers R; Cruts M; van Broeckhoven C
Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
[TBL] [Abstract][Full Text] [Related]
11. Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies.
Umeda Y; Taniguchi S; Arima K; Piao YS; Takahashi H; Iwatsubo T; Mann D; Hasegawa M
Neurosci Lett; 2004 Apr; 359(3):151-4. PubMed ID: 15050686
[TBL] [Abstract][Full Text] [Related]
12. Regulation of alternative splicing of tau exon 10.
Qian W; Liu F
Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the tau gene (MAPT) in FTDP-17: the family with Multiple System Tauopathy with Presenile Dementia (MSTD).
Spillantini MG; Murrell JR; Goedert M; Farlow M; Klug A; Ghetti B
J Alzheimers Dis; 2006; 9(3 Suppl):373-80. PubMed ID: 16914875
[TBL] [Abstract][Full Text] [Related]
14. Tau protein and neurodegeneration.
Goedert M
Semin Cell Dev Biol; 2004 Feb; 15(1):45-9. PubMed ID: 15036206
[TBL] [Abstract][Full Text] [Related]
15. The role of tau phosphorylation and cleavage in neuronal cell death.
Chun W; Johnson GV
Front Biosci; 2007 Jan; 12():733-56. PubMed ID: 17127334
[TBL] [Abstract][Full Text] [Related]
16. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
Dawson HN; Cantillana V; Chen L; Vitek MP
J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
[TBL] [Abstract][Full Text] [Related]
17. Pick's complex and FTDP-17.
Kertesz A
Mov Disord; 2003 Sep; 18 Suppl 6():S57-62. PubMed ID: 14502657
[TBL] [Abstract][Full Text] [Related]
18. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
[TBL] [Abstract][Full Text] [Related]
19. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
Sorrentino G; Bonavita V
Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468
[TBL] [Abstract][Full Text] [Related]
20. Familial FTDP-17 missense mutations inhibit microtubule assembly-promoting activity of tau by increasing phosphorylation at Ser202 in vitro.
Han D; Qureshi HY; Lu Y; Paudel HK
J Biol Chem; 2009 May; 284(20):13422-13433. PubMed ID: 19304664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
